Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: A subset analysis of EORTC 24971 study / Psyrri, Amanda; Fortpied, C.; Koutsodontis, G.; Avgeris, M.; Kroupis, C.; Goutas, N.; Menis, J.; Herman, L.; Giurgea, L.; Remenár, E.; Degardin, M.; Pateras, I. S.; Langendijk, J. A.; van Herpen, C. M. L.; Awada, A.; Germà-Lluch, J. R.; Kienzer, H. R.; Licitra, L.; Vermorken, J. B.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 28:9(2017), pp. 2213-2218. [10.1093/annonc/mdx320]
Titolo: | Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: A subset analysis of EORTC 24971 study | |
Autori: | ||
Data di pubblicazione: | 2017 | |
Rivista: | ||
Handle: | http://hdl.handle.net/11577/3290292 | |
Appare nelle tipologie: | 01.01 - Articolo in rivista |